Each year, 700,000 people die due to antibiotic resistance. A growing global population unfortunately generates a growing resistance to established antibiotic treatments—a threat that has been met with insufficient funding ...
Oct 13, 2022
0
177
Scientists have solved a long-standing mystery surrounding a cancer-promoting protein and how it causes tumor growth. The findings are an important step in the quest to make cancer drugs more effective since aggressive tumors ...
Oct 12, 2022
0
14
In a new study published in Molecular Cancer Research, Mayo Clinic researchers identified critical genomic changes in response to abiraterone acetate/prednisone, a standard treatment option for men with progressive, incurable ...
Sep 22, 2022
0
31
A powerful new genome editing technique is enabling researchers to replicate human diseases with unprecedented accuracy, promising to revolutionize the drug discovery process for a range of cancers.
Sep 21, 2022
0
95
What will the next pandemic look like? Health officials from across the globe gathered in Geneva in late August at a World Health Organization meeting to focus on how lessons learned from COVID-19 might best prepare civilization ...
Sep 20, 2022
0
10
Alveolar rhabdomyosarcoma is a type of rare pediatric tumor. For more than 40 years there have not been any new developments regarding treatment. Research led by Prof. Dr. Anton Henssen at Charité University Berlin has now ...
Sep 19, 2022
0
85
While chemotherapy drugs can be lifesaving, they don't work for all patients or for all cancers. But a team of UTM researchers is looking at new ways to use special types of light to target cancer cells resistant to current ...
Sep 14, 2022
0
85
Volodymyr is celebrating a major milestone on Wednesday—it's his final day of taking a new treatment hailed as a turning point in the fight against drug-resistant tuberculosis.
Sep 1, 2022
0
47
A new preclinical drug candidate developed by scientists at the Hackensack Meridian Center for Discovery and Innovation (CDI) shows great promise in eradicating the bacteria causing gonorrhea, according to a new publication.
Aug 23, 2022
0
18
A team of University of Michigan researchers is developing a new anti-cancer drug that is absorbed through the gut's lymphatic system rather than blood vessels, potentially outmaneuvering the molecular signaling pathways ...
Aug 17, 2022
0
134
